Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Enno Spillner, MBA
Age : 49
Public asset : 39,382 USD
Linked companies : Evotec SE - Nanobiotix SA
Summary 
Presently, Enno Spillner occupies the position of Chief Financial Officer of Evotec AG.

He is also on the board of Nanobiotix SA and Concentro Management AG and Managing Partner at Biom Venture Capital GmbH & Co. Fonds KG.

In his past career Mr. Spillner held the position of Chief Executive & Financial Officer for 4SC AG, Managing Director at Munich Innovative Biomaterials GmbH, Managing Director at ActiPac Biosystems GmbH and Head-Finance & Controlling at BioM AG Munich BioTech Development.

Mr. Spillner received an MBA from the University of Bamberg.


Current positions of Enno Spillner, MBA 
NameTitle Since
Evotec SE
(Biotechnology & Medical Research)
Chief Financial Officer 2016
Nanobiotix SA
(Biotechnology & Medical Research)
Member-Supervisory Board 2014
Concentro Management AG Deputy Chairman-Supervisory Board 2002
Biom Venture Capital GmbH & Co. Fonds KG Managing Partner 2001


Enno Spillner, MBA: Personal Network 


Most Read News 
09/11CARLOS GHOSN : Nissan Management Withholds Full Ghosn Report From Board
DJ
09/10JACK MA : Tearful Ma bids Alibaba farewell with rock star show
RE
09/11MARTIN SORRELL : Account wins put Sorrell's S4 Capital on course to double in size
RE
09/12JEFF BEZOS : Three U.S. senators urge Amazon's Bezos to check driver abuse
RE
09/14TIM COOK : Disney Chief Iger Quits Apple's Board -- WSJ
DJ
09/11THOMAS BOONE PICKENS : 'Oracle of oil' T. Boone Pickens dies at 91
RE
09/12MARTIN BOUYGUES : Alstom shares slide as top shareholder Bouygues cuts stake
RE
09/12HIROTO SAIKAWA : Departure of Nissan's Saikawa hastened by independent directors - sources
RE
09/17DANIEL LOEB : Sony rejects Loeb's proposal for chip business spin-off
RE
09/12CARLOS GHOSN : Nissan Withholds Ghosn Report -- WSJ
DJ
More news


© 2019 People and Ownership :   
Enno Spillner, MBA : Connections 
Smag Consulting SARL
Ad Bio Consulting
Alain Oncologie Consulting
Fondation A.R.CA.D.
Great North SARL
Pdc Line Pharma SASU
Pharma Licensing Club France
Pharma-Lizenz-Club Deutschland
CM Biomaterials BV
Sanofi Pasteur MSD SA (Spain)
International Drug Development Institute SA



Popular Business Leaders 
Bernard Arnault Jeff Bezos Thierry Bolloré Martin Bouygues Olivier Brandicourt Richard Branson Warren Buffett Fulvio Conti Tim Cook Benjamin De Rothschild Michael Dell Herbert Diess Jack Dorsey Patrick Drahi Sergio Ermotti Guillaume Faury Carlos Ghosn Philip Green David Henry Mark Hurd Carl Icahn Li Ka-shing Richard Li Daniel Loeb Jack Ma Ross Mcewan Lakshmi Mittal Dennis Muilenburg Rupert Murdoch Elon Musk Jean-pierre Mustier Jean-charles Naouri Ferdinand Piëch Wolfgang Porsche Sumner Redstone Wilbur Ross Hiroto Saikawa Ann Sarnoff Charles Schwab Jean-dominique Senard Christian Sewing Mark Smucker Masayoshi Son Friede Springer Rupert Stadler Bernard Tapie Carlos Tavares François Villeroy De Galhau Leslie Wexner Mark Zuckerberg
A-Z Business Leaders